Skip to main content

GOLDMAN SACHS GROUP INC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
10,380,646
+330.7% QoQ
Ownership
4.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
30,000
PutValue
$0
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. ESPR ranks #53 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 17,222,156
2026-06-30 10,380,646
2026-03-31 2,410,454
2025-12-31 2,848,216
2025-09-30 1,708,807
2025-06-30 798,754
2025-03-31 1,527,286
2024-12-31 2,753,260
2024-09-30 1,307,668
2024-06-30 916,011
2024-03-31 3,364,266
2023-12-31 1,057,401
2023-09-30 1,176,996
2023-06-30 825,711
2023-03-31 701,161
2022-12-31 728,338
2022-09-30 465,799
2022-06-30 261,558
2022-03-31 369,511
2021-12-31 287,269
2021-09-30 27,553
2021-06-30 38,484
2021-03-31 17,718
2020-12-31 98,213
2020-09-30 45,469
2020-06-30 312,161
2020-03-31 30,000
2020-03-31 30,000
2020-03-31 236,886